Cargando…
Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels
Fluorescein-di-β-d-galactopyranoside (FDG), a fluorogenic compound, is hydrolyzed by β-galactosidase in the cytoplasm of Escherichia coli to produce a fluorescent dye, fluorescein. We found that both FDG and fluorescein were substrates of efflux pumps, and have developed a new method to evaluate eff...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075257/ https://www.ncbi.nlm.nih.gov/pubmed/21533264 http://dx.doi.org/10.1371/journal.pone.0018547 |
_version_ | 1782201760296730624 |
---|---|
author | Matsumoto, Yoshimi Hayama, Kohei Sakakihara, Shouichi Nishino, Kunihiko Noji, Hiroyuki Iino, Ryota Yamaguchi, Akihito |
author_facet | Matsumoto, Yoshimi Hayama, Kohei Sakakihara, Shouichi Nishino, Kunihiko Noji, Hiroyuki Iino, Ryota Yamaguchi, Akihito |
author_sort | Matsumoto, Yoshimi |
collection | PubMed |
description | Fluorescein-di-β-d-galactopyranoside (FDG), a fluorogenic compound, is hydrolyzed by β-galactosidase in the cytoplasm of Escherichia coli to produce a fluorescent dye, fluorescein. We found that both FDG and fluorescein were substrates of efflux pumps, and have developed a new method to evaluate efflux-inhibitory activities in E. coli using FDG and a microfluidic channel device. We used E. coli MG1655 wild-type, ΔacrB (ΔB), ΔtolC (ΔC) and ΔacrBΔtolC (ΔBC) harboring plasmids carrying the mexAB-oprM (pABM) or mexXY-oprM (pXYM) genes of Pseudomonas aeruginosa. Two inhibitors, MexB-specific pyridopyrimidine (D13-9001) and non-specific Phe-Arg-β-naphthylamide (PAβN) were evaluated. The effects of inhibitors on pumps were observed using the microfluidic channel device under a fluorescence microscope. AcrAB-TolC and analogous pumps effectively prevented FDG influx in wild-type cells, resulting in no fluorescence. In contrast, ΔB or ΔC easily imported and hydrolyzed FDG to fluorescein, which was exported by residual pumps in ΔB. Consequently, fluorescent medium in ΔB and fluorescent cells of ΔC and ΔBC were observed in the microfluidic channels. D13-9001 substantially increased fluorescent cell number in ΔBC/pABM but not in ΔBC/pXYM. PAβN increased medium fluorescence in all strains, especially in the pump deletion mutants, and caused fluorescein accumulation to disappear in ΔC. The checkerboard method revealed that D13-9001 acts synergistically with aztreonam, ciprofloxacin, and erythromycin only against the MexAB-OprM producer (ΔBC/pABM), and PAβN acts synergistically, especially with erythromycin, in all strains including the pump deletion mutants. The results obtained from PAβN were similar to the results from membrane permeabilizer, polymyxin B or polymyxin B nonapeptide by concentration. The new method clarified that D13-9001 specifically inhibited MexAB-OprM in contrast to PAβN, which appeared to be a substrate of the pumps and permeabilized the membranes in E. coli. |
format | Text |
id | pubmed-3075257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30752572011-04-29 Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels Matsumoto, Yoshimi Hayama, Kohei Sakakihara, Shouichi Nishino, Kunihiko Noji, Hiroyuki Iino, Ryota Yamaguchi, Akihito PLoS One Research Article Fluorescein-di-β-d-galactopyranoside (FDG), a fluorogenic compound, is hydrolyzed by β-galactosidase in the cytoplasm of Escherichia coli to produce a fluorescent dye, fluorescein. We found that both FDG and fluorescein were substrates of efflux pumps, and have developed a new method to evaluate efflux-inhibitory activities in E. coli using FDG and a microfluidic channel device. We used E. coli MG1655 wild-type, ΔacrB (ΔB), ΔtolC (ΔC) and ΔacrBΔtolC (ΔBC) harboring plasmids carrying the mexAB-oprM (pABM) or mexXY-oprM (pXYM) genes of Pseudomonas aeruginosa. Two inhibitors, MexB-specific pyridopyrimidine (D13-9001) and non-specific Phe-Arg-β-naphthylamide (PAβN) were evaluated. The effects of inhibitors on pumps were observed using the microfluidic channel device under a fluorescence microscope. AcrAB-TolC and analogous pumps effectively prevented FDG influx in wild-type cells, resulting in no fluorescence. In contrast, ΔB or ΔC easily imported and hydrolyzed FDG to fluorescein, which was exported by residual pumps in ΔB. Consequently, fluorescent medium in ΔB and fluorescent cells of ΔC and ΔBC were observed in the microfluidic channels. D13-9001 substantially increased fluorescent cell number in ΔBC/pABM but not in ΔBC/pXYM. PAβN increased medium fluorescence in all strains, especially in the pump deletion mutants, and caused fluorescein accumulation to disappear in ΔC. The checkerboard method revealed that D13-9001 acts synergistically with aztreonam, ciprofloxacin, and erythromycin only against the MexAB-OprM producer (ΔBC/pABM), and PAβN acts synergistically, especially with erythromycin, in all strains including the pump deletion mutants. The results obtained from PAβN were similar to the results from membrane permeabilizer, polymyxin B or polymyxin B nonapeptide by concentration. The new method clarified that D13-9001 specifically inhibited MexAB-OprM in contrast to PAβN, which appeared to be a substrate of the pumps and permeabilized the membranes in E. coli. Public Library of Science 2011-04-12 /pmc/articles/PMC3075257/ /pubmed/21533264 http://dx.doi.org/10.1371/journal.pone.0018547 Text en Matsumoto et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Matsumoto, Yoshimi Hayama, Kohei Sakakihara, Shouichi Nishino, Kunihiko Noji, Hiroyuki Iino, Ryota Yamaguchi, Akihito Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels |
title | Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels |
title_full | Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels |
title_fullStr | Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels |
title_full_unstemmed | Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels |
title_short | Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels |
title_sort | evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075257/ https://www.ncbi.nlm.nih.gov/pubmed/21533264 http://dx.doi.org/10.1371/journal.pone.0018547 |
work_keys_str_mv | AT matsumotoyoshimi evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels AT hayamakohei evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels AT sakakiharashouichi evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels AT nishinokunihiko evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels AT nojihiroyuki evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels AT iinoryota evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels AT yamaguchiakihito evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels |